Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Case of the day
    • A case of Syphilitic...

    A case of Syphilitic Gumma : Extremely rare type of Tertiary syphilis

    Written by Hina Zahid Published On 2018-12-19T18:00:05+05:30  |  Updated On 19 Dec 2018 6:00 PM IST
    A case of Syphilitic Gumma :  Extremely rare type of Tertiary syphilis

    A case of Syphilitic Gumma an extremely rare type of Tertiary syphilis has been published in the Annals of Dermatology. Dr Jungyoon Moon at Department of Dermatology, SMG-SNU Boramae Medical Center, Seoul, Korea and colleagues have reported the case.


    Syphilis is transmitted from person to person by direct contact with a syphilitic sore, known as a chancre. The average time between the acquisition of syphilis and the start of the first symptom is 21 days but can range from 10 to 90 days. Almost one-third of patients with primary or secondary syphilis who were untreated can develop the late manifestations such as cutaneous syphilis, neurosyphilis, or cardiovascular syphilis.


    According to history a 48-year-old woman presented with a painless ulcerated plaque on her face for 2 months. At another hospital, she had been treated with antibiotics and antiviral therapies with repetitive dressings, which was not successful. She was previously healthy and denied trauma and skin cancer history.


    A nontender dusky-red to brown plaque with deep, centrally punched-out ulcers covered with some crusts and necrotic debris. (B) A significant improvement shown after three intramuscular injections of penicillin G.

    Courtesy Ann Dermatol. 2018 Dec;30(6):749-751. The Korean Dermatological Association and The Korean Society for Investigative Dermatology

    Fig. 1. (A) A non-tender dusky-red to the brown plaque with deep, centrally punched-out ulcers covered with some crusts and necrotic debris. (B) A significant improvement is shown after three intramuscular injections of penicillin G.


    Her physical examination showed a 4×4 cm crater-shaped plaque with crusts and oozing. Provisional diagnosis included pyoderma gangrenosum and squamous cell carcinoma. Skin biopsy demonstrated extensive necrosis and large areas of granulomatous inflammation within the dermis, including numerous multinucleated giant cells and marked lymphoplasmacytic infiltrates.

    A rapid plasma reagin test was reactive (1:16), and fluorescent treponemal antibody-absorption (FTA-ABS) tests for immunoglobulin M (IgM) and immunoglobulin G were both positive. A human immunodeficiency virus (HIV) test was negative. Only then did the patient mention that she was inadequately treated for syphilis 20 years ago.

    Taken together, she was finally diagnosed with a syphilitic gumma. Further workup including cerebrospinal fluid analysis did not reveal any evidence of internal organ involvement. The lesion was significantly improved after three intramuscular injections of 2.4 million units of penicillin G.

    Carry Home Points:-




    • Cutaneous tertiary syphilis accounts for about 16% of them. The time to progress to tertiary syphilis varies from several months to 35 years after infection.

    • As cutaneous tertiary syphilis clinically simulates many other skin diseases, its diagnosis should depend on a comprehensive interpretation of the patient's medical history, pathologic findings, and serology results.


    For more details click on the link: https://doi.org/10.5021/ad.2018.30.6.749
    cutaneous tertiary syphilisHIVhuman immunodeficiency virusimmunoglobulin Mlymphoplasmacytic infiltratesmasqueraderpainless ulcerated plaqueprimarysecondaryskin cancersquamous cell carcinomasyphilitic gummaSyphlisTertiary
    Source : With inputs from Annals of Dermatology

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Hina Zahid
    Hina Zahid
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok